Open Access<p>Cost-Minimization Analysis of Dexmedetomidine Compared to Other Sedatives for Short-Term Sedation During Mechanical Ventilation in the United States</p>
Author(s) -
Jyoti Aggarwal,
Jacqueline Lustrino,
Jennifer Stephens,
Diana Morgenstern,
Wing Yu Tang
Publication year - 2020
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s242994
Subject(s) - dexmedetomidine , medicine , propofol , midazolam , sedation , sedative , mechanical ventilation , anesthesia , cost minimization analysis , adverse effect , emergency medicine , surgery
Mechanical ventilation (MV) remains a substantial cost driver in intensive care units (ICU) in the United States (US). Evaluations of standard sedation treatments used to relieve pain and discomfort in this setting have found varying impacts on ICU length of stay. This cost analysis examines both length-of=stay costs and the total cost implications among MV patients receiving common sedative treatments (dexmedetomidine, propofol, or midazolam) in short-term sedation settings (<24 hours).